...
首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >CD19 Targeted CAR-T Therapy Followed by Haploidentical HSCT for Refractory/Relapsed Acute Leukemia: Superior Therapeutic Efficacy
【24h】

CD19 Targeted CAR-T Therapy Followed by Haploidentical HSCT for Refractory/Relapsed Acute Leukemia: Superior Therapeutic Efficacy

机译:CD19靶向CAR-T治疗,然后是HAPLoidentical HSCT用于难治性/复发急性白血病:优异的治疗效果

获取原文
获取原文并翻译 | 示例

著录项

  • 来源
  • 作者单位

    Bone Marrow Transplantation Center The First Affiliated Hospital School of Medicine Zhejiang;

    Bone Marrow Transplantation Center The First Affiliated Hospital School of Medicine Zhejiang;

    Bone Marrow Transplantation Center The First Affiliated Hospital School of Medicine Zhejiang;

    Bone Marrow Transplantation Center The First Affiliated Hospital School of Medicine Zhejiang;

    Bone Marrow Transplantation Center The First Affiliated Hospital School of Medicine Zhejiang;

    Bone Marrow Transplantation Center The First Affiliated Hospital School of Medicine Zhejiang;

    Innovative Cellular Therapeutics Co. Ltd;

    Innovative Cellular Therapeutics Co. Ltd;

    The First Affiliated Hospital School of Medicine Zhejiang University;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 治疗学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号